Inxight Drugs

U.S. Department of Health & Human Services Divider Arrow

National Institutes of Health Divider Arrow

NCATS

Return Home Inxight Drugs

Home
Browse Drugs
Search
- Structure Search
- Sequence Search
Downloads
About

Show Filters

Hide Filters

Development Status

Possibly Marketed Outside US

2

All Match

Any Match

Exclude Selected

Exclude Selected

Approval Year

1999

2

All Match

Any Match

Exclude Selected

Exclude Selected

Condition

Hepatocellular carcinoma

2

All Match

Any Match

Exclude Selected

Exclude Selected

Treatment Modality

Diagnostic

2

All Match

Any Match

Exclude Selected

Exclude Selected

Substance Class

Chemical

2

All Match

Any Match

Exclude Selected

Exclude Selected

Code System

CAS

2

CHEBI

2

ECHA (EC/EINECS)

2

FDA UNII

2

PUBCHEM

2

All Match

Any Match

Exclude Selected

Exclude Selected

Substance Form

Principal Form

1

Salts, Hydrates, Esters, etc.

1

All Match

Any Match

Exclude Selected

Exclude Selected

Showing 1 - 2 of 2 results

First page disabled
Previous page disabled
1
Next page disabled
Next page disabled

GLYCOCHOLIC ACID

G59NX3I3RT

Export Data
Search for Structure

Status:

Possibly Marketed Outside US

First approved in 1999

Class (Stereo):

CHEMICAL (ABSOLUTE)

Conditions:

Hepatocellular carcinoma

Glycocholic acid (GCA) is an important metabolite of bile acids, a conjugate of cholic acid with glycine. GCA urine levels are expected to be a specific diagnostic biomarker for hepatocellular carcinoma (HCC). The average GCA concentrations of HCC pa...

tients in plasma and urine were about 25 and 2.8 times than that of healthy volunteers.

SODIUM GLYCOCHOLATE

V06CXA1W3K

Export Data
Search for Structure

Status:

Possibly Marketed Outside US

First approved in 1999

Class (Stereo):

CHEMICAL (ABSOLUTE)

Conditions:

Hepatocellular carcinoma

Glycocholic acid (GCA) is an important metabolite of bile acids, a conjugate of cholic acid with glycine. GCA urine levels are expected to be a specific diagnostic biomarker for hepatocellular carcinoma (HCC). The average GCA concentrations of HCC pa...

tients in plasma and urine were about 25 and 2.8 times than that of healthy volunteers.

HHS VULNERABILITY DISCLOSURE

For language access assistance, contact the NCATS Public Information Officer

National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966


			version 1.1